The global Metagenomic Market, with a value of USD 1.41 billion in 2022, is projected to reach USD 5.57 billion by 2032, exhibiting a revenue CAGR of 16.5% during the forecast period. The primary driver of market growth is the increasing demand for metagenomic sequencing and analysis across various fields, including diagnostics, drug discovery, Environmental Monitoring, and agricultural...